ETA-DOC-0004·Compound index·Rev 1·Methodology v0.1Provisional — reviewer not yet appointed
compound index · D, page 1 of 3 · methodology v0.1 · reviewer not yet appointed
Compound index · D ETA-DOC-0004

Compound index — D

597 substances begin with D. 2 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, D&c Black No. 2 – Desipramine Hydrochloride.

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
D&c Black No. 2 US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004796
D(+)-alpha,gamma-Dihydroxy-N-(3-hydroxypropyl)-beta,beta-dimethylbutyramide CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004794
D(-)-lactic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004795
D, l-alpha tocopherol CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004797
D-3-Hydroxybutyrate CA-NHP Not yet graded
CA licensed ingredient
Market presence635 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000446
d-alpha Tocopherol CA-NHP Not yet graded
CA licensed ingredient
Market presence25 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-001206
d-alpha tocopheryl CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-001207
D-alpha-Tocopheryl Succinate CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-001253
D-bis(N-Pantothenyl-beta-aminoethyl) disulfide CA-NHP Not yet graded
CA licensed ingredient
Market presence17 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002625
D-Chiro-inositol CA-NHP Not yet graded
CA licensed ingredient
Market presence92 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003800
d-Choline hydroxide 2,3-dihydroxypropyl hydrogen phosphate inner salt CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003887
D-Galacto-L-arabinan CA-NHP Not yet graded
CA licensed ingredient
Market presence127 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006597
D-gamma-tocopherol CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006655
D-Glucaric acid calcium salt CA-NHP Not yet graded
CA licensed ingredient
Market presence55 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006815
D-glucaro-1,4-lactone CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006816
D-Gluconic acid, monopotassium salt CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006821
D-Glucose, O-beta-D-galactopyranosyl-(1-4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-3)-O-beta-D-galactopyranosyl-(1-4)- CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006833
D-Glucuronic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006835
D-Glucuronic acid, gamma-lactone CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006836
D-Glucurono-gamma-lactone CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-006837
D-Mandelonitrile-beta-D-glucosido-6-beta-D-glucoside CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009180
D-Mannose CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
Market presence195 Canadian licensed products
Parts in scopeSubstance
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-009218
d-psi-Ephedrine CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012086
D-Ribose-L-cysteine CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-012590
D-Tagatose EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Stimulates the growth of beneficial bacteria in the gut”Non-authorisedArt.13(1)EFSA opinion
“Stimulates the growth of beneficial bacteria in the gut”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-014235
Dabigatran US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004798
Dabigatran Etexilate US-DRUG Not yet graded
US: anda
Class as recordedDirect Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]
Earliest US approval2010
Market presence74 US product listings · 14 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004799
dabigatran etexilate mesilate EU-MED Not yet graded
EU medicine: Application withdrawn, Authorised
Class as recordedB01AE07
Market presence4 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004800
dabrafenib mesilate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01EC02
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004802
Dabrafenib Mesylate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]
Earliest US approval2013
Market presence12 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004801
Dacarbazine US-DRUG Not yet graded
US: anda
Class as recordedAlkylating Activity [MoA]; Alkylating Drug [EPC]
Earliest US approval1975
Market presence6 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004803
Daclatasvir Dihydrochloride EU-MEDUS-DRUG Not yet graded
EU medicine: ExpiredUS: bulk ingredient
Class as recordedJ05AP07
Earliest US approval2015
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004805
Daclatasvir Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004804
Daclizumab EU-MEDUS-DRUG Not yet graded
EU medicine: Withdrawn
Class as recordedL04AA08; L04AC01
Earliest US approval2016
Market presence1 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004806
Dacomitinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL01EB07
Earliest US approval2018
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004807
Dacryodes edulis EU-NOVEL Not yet graded
Not novel in food
also: Native pear; African pear; bush butter tree
Parts in scopeFruits
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-004808
Dactinomycin US-DRUG Not yet graded
US: anda
Class as recordedActinomycin [EPC]; Nucleic Acid Synthesis Inhibitors [MoA]; Protein Synthesis Inhibitors [MoA]
Earliest US approval1964
Market presence7 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004809
Dactylis Glomerata Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence65 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004810
Dactylis Glomerata TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004811
Dactylopius coccus CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004812
Dactylorhiza incarnata subsp. incarnata CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004813
Daemonorops draco CA-NHP Not yet graded
CA licensed ingredient
Market presence48 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004814
Daidzein CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004815
Daikon US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004816
Dairy (low fat dairy) *Dairy refers to cow's milk, yogurt and cheese EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Dairy in an energy restricted diet helps weight loss. Consuming dairy foods, as part of your weight loss diet, will help weight loss. Consuming dairy foods, as part of your weight loss diet, will help weight maintenance.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-004817
Dairy product (milk beverage) enriched with milk peptide and magnesium EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Helps to moderate signs of anxiety in mildly stress-sensitive adults due to its milk peptide and magnesium content.”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-004818
Dairy products (milk and cheese) EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Three portions of dairy food everyday, as part of a balanced diet, may help promote a healthy body weight during childhood and adolescence.”Non-authorisedArt.14(1)(b)EFSA opinion
“Dairy foods (milk and cheese) promote dental health in children.”Non-authorisedArt.14(1)(b)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-004819
Dairy products containing the combination of three probiotic ingredients; Lactobacillus casei F19, Bifidobacterium lactis Bb12, Lactobacillus acidophilus La5 EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Balances the gut flora. Supports a healthy gut flora. Support gastrointestinal conditions during antibiotic treatment”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-004820
Dalbavancin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedJ01XA04; Lipoglycopeptide Antibacterial [EPC]; Lipoglycopeptides [CS]
Earliest US approval2014
Market presence10 US product listings · 6 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004821
Dalbavancin B0 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004822
Dalbergia odorifera CA-NHP Not yet graded
CA licensed ingredient
Market presence31 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004823
Dalea Foliolosa Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Inactivated Poliovirus Vaccine [EPC]; Inactivated [CS]; Live
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004824
Dalfampridine US-DRUG Not yet graded
US: anda
Class as recordedPotassium Channel Antagonists [MoA]; Potassium Channel Blocker [EPC]
Earliest US approval2010
Market presence23 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004825
Dalfopristin US-DRUG Not yet graded
Earliest US approval1999
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004826
Dalotuzumab US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Amino Acid [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004827
Dalteparin Sodium US-DRUG Not yet graded
US: nda
Class as recordedAnti-coagulant [EPC]; Heparin; Low Molecular Weight Heparin [EPC]; Low-Molecular-Weight [CS]
Earliest US approval1994
Market presence9 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004828
Damiana CA-NHP Not yet graded
CA licensed ingredient
Market presence29 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004829
Damoctocog alfa pegol EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB02BD02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004830
Danaparoid Sodium US-DRUG Not yet graded
Earliest US approval1996
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004831
Danazol US-DRUG Not yet graded
US: anda
Class as recordedAndrogen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]
Earliest US approval1976
Market presence21 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004832
Danicopan EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Complement Factor D Inhibitor [EPC]; Complement Factor D Inhibitors [MoA]; L04AJ09
Earliest US approval2024
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004833
Danio rerio CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004834
Danio Rerio EGG US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004835
Danofloxacin Mesylate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004836
Dantrolene Sodium EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedDecreased Striated Muscle Contraction [PE]; Decreased Striated Muscle Tone [PE]; M03CA01; Skeletal Muscle Relaxant [EPC]
Earliest US approval1974
Market presence35 US product listings · 8 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004837
Dapagliflozin EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedA10BD; A10BK01; Biguanide [EPC]; Biguanides [CS]
Earliest US approval2014
Market presence80 US product listings · 37 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004838
Dapagliflozin 2,3-Butanediol Monohydrate US-DRUG Not yet graded
US: anda
Class as recordedSodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004839
Dapagliflozin Propanediol EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedA10BD15; A10BD21; A10BK01; Biguanide [EPC]
Market presence53 US product listings · 5 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004841
Dapagliflozin || Metformin US-DRUG Not yet graded
Earliest US approval2025
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004840
Dapagliflozin, Saxagliptin Monohydrate US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004842
Daphne genkwa CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004843
Daphne indica CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004844
Daphne mezereum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004845
Daphne Mezereum Bark US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Actively Acquired Immunity [PE]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence130 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004846
Daphne Mezereum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004847
Daphne Odora Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Cell-mediated Immunity [PE]; Cholinergic Nicotinic Agonist [EPC]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004848
Daphniphyllum calycinum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004849
Dapiprazole Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1990
Market presence2 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004850
Dapivirine US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004851
Dapoxetine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004852
Daprodustat EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: bulk ingredient
Class as recordedB03XA; Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]; Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]
Earliest US approval2023
Market presence16 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004853
Dapsone US-DRUG Not yet graded
US: anda
Class as recordedSulfone [EPC]; Sulfones [CS]
Earliest US approval1979
Market presence70 US product listings · 29 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004854
Daptomycin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedJ01XX09; Lipopeptide Antibacterial [EPC]; Lipopeptides [CS]
Earliest US approval2003
Market presence64 US product listings · 33 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004855
Daratumumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; CD38-directed Antibody Interactions [MoA]; CD38-directed Cytolytic Antibody [EPC]; Endoglycosidase [EPC]
Earliest US approval2015
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004856
Daratumumab And Hyaluronidase-Fihj US-DRUG Not yet graded
Earliest US approval2020
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004857
Darbepoetin Alfa EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: bla
Class as recordedB03XA02; Erythropoiesis-stimulating Agent [EPC]; Erythropoietin [CS]; Increased Erythroid Cell Production [PE]
Earliest US approval2001
Market presence14 US product listings · 1 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004858
Daridorexant EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedN05CJ03; Orexin Receptor Antagonist [EPC]; Orexin Receptor Antagonists [MoA]
Earliest US approval2022
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004859
Daridorexant ([(S)-2-(5-chloro-4-methyl-1H benzo[d]imidazol-2-yl)-2methylpyrrolidin-1-yl](5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone) US-CSA Not yet graded
CSA Schedule IV
also: Daridorexant -2- -2methylpyrrolidin-1-yl] phenyl)methanone)
Class as recordedDEA: depressant
DEA other namesQUVIVIQ
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-004860
Darifenacin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedCholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]; G04BD10
Earliest US approval2004
Market presence24 US product listings · 10 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004861
Darolutamide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL02BB
Earliest US approval2019
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004862
Darunavir EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, ExpiredUS: anda
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitor [EPC]; Cytochrome P450 3A Inhibitors [MoA]
Earliest US approval2006
Market presence32 US product listings · 16 FDA applications · 6 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004863
Darunavir And Cobicistat US-DRUG Not yet graded
Earliest US approval2026
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004864
Darunavir And Ritonavir US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004865
Darunavir Ethanolate US-DRUG Not yet graded
US: anda
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitor [EPC]; Cytochrome P450 3A Inhibitors [MoA]
Earliest US approval2015
Market presence21 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004866
Darunavir Propylene Glycolate US-DRUG Not yet graded
US: anda
Class as recordedCytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Protease Inhibitor [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004867
darvadstrocel EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedL04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004868
Dasabuvir Sodium EU-MEDUS-DRUG Not yet graded
EU medicine: Withdrawn
Class as recordedJ05AP09
Earliest US approval2014
Market presence2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004869
Dasatinib EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedCytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; L01EA02; Protein Kinase Inhibitors [MoA]
Earliest US approval2006
Market presence125 US product listings · 12 FDA applications · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004870
Dashamula CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004871
Dasiglucagon EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedAntihypoglycemic Agent [EPC]; Glucagon Receptor Agonists [MoA]; H04AA02; Increased Glycogenolysis [PE]
Earliest US approval2021
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004872
dasiprotimut-t EU-MED Not yet graded
EU medicine: Refused
Class as recordedL03AX
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004873
Datopotamab Deruxtecan EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bla
Class as recordedL01FX35
Market presence3 US product listings · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004874
Datopotamab Deruxtecan-Dlnk US-DRUG Not yet graded
Earliest US approval2025
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004875
Datura metel CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004876
Datura Metel Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004877
Datura Stramonium CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence113 US product listings · 1 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004878
Datura Stramonium Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004879
Datura Stramonium Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004880
Daucus carota CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence509 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“For eye health - promotes maintenance of vision apparatus functions Improves dark adaptation Strengthens eye capillaries Reduces eye tiredness in case of vision exertion”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers
Etalyn identifierETA-C-004881
Daucus carota L. EU-NOVEL Not yet graded
Not novel in food
Parts in scopeRoots
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-004882
Daucus carota sativa CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004883
Daucus carota subsp. carota CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004884
Daucus carota subsp. sativus CA-NHP Not yet graded
CA licensed ingredient
Market presence112 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004885
Daucus gingidium EU-NOVEL Not yet graded
Status not stated
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-004886
Daunorubicin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAnthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; L01XY01; Nucleic Acid Synthesis Inhibitors [MoA]
Earliest US approval1979
Market presence10 US product listings · 12 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004887
Daxibotulinumtoxina-Lanm US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004888
DDT CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004889
Deacetylbisacodyl US-DRUG Not yet graded
US: otc monograph drug
Class as recordedIncreased Large Intestinal Motility [PE]; Stimulant Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004890
Deanol CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Market presence1 US product listings · 1 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004891
Debaryomyces hansenii CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Candida famata
Market presence1 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-004892
Decaffeinated green (unroasted) coffee bean extract produced from Coffea canephora robusta (plant:extract ratio between 6:1 to 8:1). The active ingredients contained in the green coffee extract are chlorogenic acids (>45% w/w). The chlorogenic acids main EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“As an aid to weight loss and weight control as part of a calorie controlled diet. Acts by reducing absorption of sugar (glucose) from the digestive tract.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-004893
Decamethonium Bromide US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004894
Decitabine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedL01BC08; L01BC58; Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
Earliest US approval2006
Market presence38 US product listings · 23 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004895
Decoquinate US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004896
Decrease of trans fatty acids; EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Reduction of the intake of the trans fatty acids under 1 % of the daily energy intake helps to maintain the normal total cholesterol and LDL cholesterol levels in blood.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-004897
Decyl Glucoside US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004898
Decyl Oleate US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004899
Defactinib Hydrochloride US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004900
defatted powder of Arachis hypogaea L EU-MED Not yet graded
EU medicine: Authorised
Class as recordedV01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004901
Defatted wheat germ protein CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004902
Deferasirox EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedCytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]
Earliest US approval2005
Market presence113 US product listings · 38 FDA applications · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004903
Deferiprone EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedIron Chelating Activity [MoA]; Iron Chelator [EPC]; V03AC02
Earliest US approval2011
Market presence14 US product listings · 6 FDA applications · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004904
Deferoxamine Mesylate US-DRUG Not yet graded
US: anda
Class as recordedIron Chelating Activity [MoA]; Iron Chelator [EPC]
Earliest US approval1968
Market presence14 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004905
defibrotide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Class as recordedB01AX01
Earliest US approval2016
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004906
Deflazacort US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval2017
Market presence52 US product listings · 13 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004907
Degarelix EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL02BX02
Earliest US approval2008
Market presence17 US product listings · 2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004908
Deglycyrrhizinated licorice CA-NHP Not yet graded
CA licensed ingredient
Market presence151 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004909
Dehydrated Alcohol US-DRUG Not yet graded
US: anda
Earliest US approval2018
Market presence1 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004910
Dehydroacetic Acid US-DRUG Not yet graded
US: otc monograph final
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-coagulant [EPC]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004911
Dehydrochloromethyltestosterone US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
DEA other namesOral-Turinabol
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-004912
Delafloxacin Meglumine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedFluoroquinolone Antibacterial [EPC]; Fluoroquinolones [CS]; J01MA23
Earliest US approval2017
Market presence4 US product listings · 2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004913
Delamanid EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ04AK06
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004914
delandistrogene moxeparvovec EU-MED Not yet graded
EU medicine: Refused
Class as recordedM09AX15
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004915
Delavirdine Mesylate US-DRUG Not yet graded
Earliest US approval1997
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004916
Delgocitinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: nda
Class as recordedD11AH11; Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
Earliest US approval2025
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004917
Delorazepam US-CSAUS-DRUG Not yet graded
CSA Schedule IVUS: bulk ingredient
Class as recordedDEA: depressant
Market presence1 US product listings
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004918
Delphinium Ajacis Seed US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004919
Delphinium consolida CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004920
Delphinium consolida L. EU-NOVEL Not yet graded
Not novel in food
also: Ceratostanthus consolida Schur
Parts in scopeFlowers
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-004921
Delphinium staphisagria CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004922
Delphinium Staphisagria Seed US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence173 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004923
Delphinium Staphisagria Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004924
Δ1-Dihydrotestosterone US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
DEA other names1-Testosterone
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-000195
Delta5-24-isoergosten-3beta-ol CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004927
Demannose US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004928
Demecarium Bromide US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1959
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004929
Demeclocycline Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedTetracycline-class Antimicrobial [EPC]; Tetracyclines [CS]
Earliest US approval1960
Market presence11 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004930
Dendrobium chrysanthum CA-NHP Not yet graded
CA licensed ingredient
Market presence29 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004931
Dendrobium chrysotoxum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004932
Dendrobium fimbriatum CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004933
Dendrobium loddigesii CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004934
Dendrobium nobile CA-NHPEU-NOVEL Not yet graded
Novel, not yet authorisedCA licensed ingredient
also: Callista nobilis Kuntze; Dendrobium coerulescen Wall. ex Lindl.
Market presence84 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-004935
Dendrobium officinale CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004936
Dendrobium Officinale Stem US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004937
Dendrocalamus asper CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Bambusa aspera
Market presence4 Canadian licensed products
Parts in scopeStem (botanically immature shoots)
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-004938
Dendrocalamus latiflorus EU-NOVEL Not yet graded
Not novel in food
also: Bambusa latiflora.
Parts in scope• Stem (botanically immature shoots)
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-004939
Dendryphiella Vinosa US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004940
Dengue virus EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BX04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004941
Denileukin Diftitox US-DRUG Not yet graded
US: bla
Class as recordedCD25-directed Cytotoxin [EPC]; Diphtheria Toxin [CS]; Interleukin-2 [CS]; Recombinant Fusion Proteins [CS]
Earliest US approval1999
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004942
Denileukin Diftitox-Cxdl US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2024
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004943
Denosumab EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, OpinionUS: bla
Class as recordedM05BX04; RANK Ligand Blocking Activity [MoA]; RANK Ligand Inhibitor [EPC]
Earliest US approval2010
Market presence23 US product listings · 1 FDA applications · 32 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004944
Denosumab-Adet US-DRUG Not yet graded
Earliest US approval2026
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004945
Denosumab-Bbdz US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004946
Denosumab-Bmwo US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004947
Denosumab-Bnht US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004948
denosumab-desu US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004949
Denosumab-Dssb US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2025
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004950
Denosumab-Kyqq US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004951
Denosumab-Mobz US-DRUG Not yet graded
Earliest US approval2025
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004952
Denosumab-Nxxp US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004953
Denosumab-Qbde US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004954
Dens draconis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004955
Deodorised cocoa butter EU-NOVEL Not yet graded
Not novel in food
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-004956
Deoxycholic Acid US-DRUG Not yet graded
US: bulk ingredient
Class as recordedCytolytic Agent [EPC]; Decreased Cell Membrane Integrity [PE]
Earliest US approval2015
Market presence3 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004957
Deoxymutaaspergillic Acid US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Catecholamine [EPC]; Catecholamines [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004958
Depemokimab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedR03DX12
Market presence2 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-004959
Depemokimab-Ulaa US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004960
depreotide trifluoroacetate EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedV09IA05
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004961
Deracoxib US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004962
Dermatophagoides Farinae US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Allergens [Chemical/Ingredient]
Market presence22 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004963
Dermatophagoides Pteronyssinus US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Allergens [Chemical/Ingredient]
Market presence24 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004964
Derquantel US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004965
Descurainia sophia CA-NHP Not yet graded
CA licensed ingredient
Market presence41 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004966
Descurainia Sophia Seed US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004967
Deserpidine US-DRUG Not yet graded
Earliest US approval1957
Market presence5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004968
Desethyl Atrazine US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004969
Desflurane US-DRUG Not yet graded
US: anda
Class as recordedGeneral Anesthesia [PE]; General Anesthetic [EPC]
Earliest US approval1992
Market presence7 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004970
Desflurane, (R)- US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004971
Desiccated Liver CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004972
Desipramine Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedTricyclic Antidepressant [EPC]
Earliest US approval1964
Market presence51 US product listings · 18 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004973